Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction". (15th March 2016)

Record Type:: Journal Article
Title:: Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction". (15th March 2016)
Main Title:: Reply to the letter "thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction"
Authors:: Maulik, Nilanjana
Thirunavukkarasu, Mahesh
Selvaraju, Vaithinathan
Suresh, Sumanth C.
Abstract:
Is Part Of:: International journal of cardiology. Volume 207(2016)
Journal:: International journal of cardiology
Issue:: Volume 207(2016)
Issue Display:: Volume 207, Issue 2016 (2016)
Year:: 2016
Volume:: 207
Issue:: 2016
Issue Sort Value:: 2016-0207-2016-0000
Page Start:: 277
Page End:: 278
Publication Date:: 2016-03-15
Subjects:: Thioredoxin-1 -- Mesenchymal stem cells -- Gene therapy -- Angiogenesis -- Myocardial infarction
Cardiology -- Periodicals
Electronic journals
616.12
Journal URLs:: http://www.clinicalkey.com/dura/browse/journalIssue/01675273 ↗
http://www.sciencedirect.com/science/journal/01675273 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.ijcard.2016.01.047 ↗
Languages:: English
ISSNs:: 0167-5273
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4542.158000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 2434.xml